Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 4643

Sort by

Sort Order Select

Journal Articles

A slow-go prognosis for older patients with newly diagnosed AML

Gary Schiller

Blood (2021) 138 (7): 501–502.

https://doi.org/10.1182/blood.2021012456

Published: 2021

Journal Articles

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Blood (2021) 138 (7): 571–583.

https://doi.org/10.1182/blood.2021010735

Published: 2021

Includes: Supplemental data

Journal Articles

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Blood (2021) 138 (7): 507–519.

https://doi.org/10.1182/blood.2021011103

Published: 2021

Includes: Supplemental data

Journal Articles

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Blood (2021) 138 (5): 387–400.

https://doi.org/10.1182/blood.2020008812

Published: 2021

Includes: Supplemental data

Journal Articles

Up-front ixazomib in older patients with myeloma

Jean-Luc Harousseau, Mohamad Mohty

Blood (2021) 137 (26): 3584–3586.

https://doi.org/10.1182/blood.2021011262

Published: 2021

Journal Articles

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Evangelos Terpos, Ioannis P. Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D. Sklirou, Ioannis Ntanasis-Stathopoulos, Eleni-Dimitra Papanagnou, Despina Fotiou, Efstathios Kastritis, Meletios A. Dimopoulos

Blood (2021) 137 (26): 3674–3676.

https://doi.org/10.1182/blood.2021011904

Published: 2021

Journal Articles

Addition by subtraction

Sonja Zweegman, Tanya M. Wildes

Blood (2021) 137 (22): 3005–3006.

https://doi.org/10.1182/blood.2021011144

Published: 2021

Journal Articles

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

Blood (2021) 137 (20): 2785–2799.

https://doi.org/10.1182/blood.2020005244

Published: 2021

Includes: Supplemental data

Journal Articles

Emerging therapies for inv(16) AML

Sridevi Surapally, Daniel G. Tenen, John A. Pulikkan

Blood (2021) 137 (19): 2579–2584.

https://doi.org/10.1182/blood.2020009933

Published: 2021

Journal Articles

The long road: improving outcome in elderly “unfit” AML?

Bob Löwenberg, Gerwin Huls

Blood (2020) 135 (24): 2114–2115.

https://doi.org/10.1182/blood.2020005651

Published: 2020

Journal Articles

The benefit of CAR T cells in older patients

Michael R. Bishop

Blood (2020) 135 (23): 2020–2021.

https://doi.org/10.1182/blood.2020005592

Published: 2020

Journal Articles

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

Sattva S. Neelapu, Caron A. Jacobson, Olalekan O. Oluwole, Javier Munoz, Abhinav Deol, David B. Miklos, Nancy L. Bartlett, Ira Braunschweig, Yizhou Jiang, Jenny J. Kim, Lianqing Zheng, John M. Rossi, Frederick L. Locke

Blood (2020) 135 (23): 2106–2109.

https://doi.org/10.1182/blood.2019004162

Published: 2020

Includes: Supplemental data

Journal Articles

Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals

Isabelle A. van Zeventer, Aniek O. de Graaf, Hanneke J. C. M. Wouters, Bert A. van der Reijden, Melanie M. van der Klauw, Theo de Witte, Marianne A. Jonker, Luca Malcovati, Joop H. Jansen, Gerwin Huls

Blood (2020) 135 (14): 1161–1170.

https://doi.org/10.1182/blood.2019004362

Published: 2020

Includes: Supplemental data

Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin

Blood (2020) 135 (6): 449–452.

https://doi.org/10.1182/blood.2019003662

Published: 2020

Includes: Supplemental data

Journal Articles

Concordance for clonal hematopoiesis is limited in elderly twins

Margarete A. Fabre, Thomas McKerrell, Maximillian Zwiebel, M. S. Vijayabaskar, Naomi Park, Philippa M. Wells, Roland Rad, Panagiotis Deloukas, Kerrin Small, Claire J. Steves, George S. Vassiliou

Blood (2020) 135 (4): 269–273.

https://doi.org/10.1182/blood.2019001807

Published: 2020

Includes: Supplemental data

Journal Articles

Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

Blood (2019) 134 (24): 2209–2217.

https://doi.org/10.1182/blood.2019000748

Published: 2019

Includes: Supplemental data

Journal Articles

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Heidi D. Klepin

Blood (2019) 134 (23): 2005–2012.

https://doi.org/10.1182/blood.2019001299

Published: 2019

Journal Articles

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

Rebecca L. Olin

Blood (2019) 134 (23): 2013–2021.

https://doi.org/10.1182/blood.2019001300

Published: 2019

Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Blood (2019) 134 (Supplement_2): LBA-3.

https://doi.org/10.1182/blood-2019-132405

Published: 2019

Journal Articles

The Spectrum of Exomic Mutation in Elderly Myeloma Differs Substantially from Patients at Younger Ages Consistent with a Different Evolutionary Trajectory to Full Blown Disease Based on Age of Onset

Louis Williams, MD MBA, Eileen M Boyle, MD MSc, Faith E. Davies, MD, Brian A Walker, PhD, Cody Ashby, PhD, Michael A Bauer, PhD, Christopher P. Wardell, PhD MSc, BSc, Erin Flynt, Anjan Thakurta, Gareth Morgan, MD PhD

Blood (2019) 134 (Supplement_1): 4346.

https://doi.org/10.1182/blood-2019-130079

Published: 2019

NARROW

A slow-go prognosis for older patients with newly diagnosed AML

Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Up-front ixazomib in older patients with myeloma

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose

Addition by subtraction

Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas

Emerging therapies for inv(16) AML

The long road: improving outcome in elderly “unfit” AML?

The benefit of CAR T cells in older patients

Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma

Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Concordance for clonal hematopoiesis is limited in elderly twins

Immune thrombotic thrombocytopenic purpura in older patients: prognosis and long-term survival

Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice

Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

The Spectrum of Exomic Mutation in Elderly Myeloma Differs Substantially from Patients at Younger Ages Consistent with a Different Evolutionary Trajectory to Full Blown Disease Based on Age of Onset

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only